Purification of recombinant C-reactive protein mutants

Area of Science:

• Immunology
• Biochemistry
• Molecular Biology

Background:

• C-reactive protein (CRP) is an acute phase protein involved in innate immunity.
• CRP localizes to inflammatory sites like atherosclerotic lesions and amyloid deposits.
• CRP exhibits protective roles in models of pneumococcal disease, atherosclerosis, and arthritis.

Purpose of the Study:

• To develop and report methods for purifying pentameric recombinant wild-type and mutant C-reactive protein (CRP).
• To facilitate structure-function relationship studies of CRP by enabling purification of mutants with altered ligand-binding properties.
• To investigate the role of CRP's recognition and effector functions in host defense.

Main Methods:

• Site-directed mutagenesis was used to create CRP mutants, including those unable to bind phosphocholine.
• Recombinant CRP mutants were expressed and secreted by mammalian cells.
• Novel purification strategies were developed for mutant CRP forms, particularly those with impaired calcium or phosphocholine binding.

Main Results:

• Established methods for purifying wild-type CRP.
• Developed and validated new purification strategies for various CRP mutants.
• Successfully purified pentameric recombinant wild-type and mutant CRP from mammalian cell culture media.

Conclusions:

• The reported methods enable the purification of recombinant CRP mutants, essential for dissecting CRP's structure-function relationships.
• These purification techniques are vital for studying CRP's role in inflammatory diseases and host defense.
• Understanding CRP mutant purification is key to advancing research on innate immunity and associated pathologies.